Intranasal Pathogenesis‐Adaptive Nanotherapeutics Reinstate Regenerative Competence for Post‐Stroke Neural Repair
Advanced Materials · 10.11.2026
DOI: 10.1002/adma.75679 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 10.11.2026. Verfasst von Yue Yin und 15 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing, P. R. China. Die Arbeit nennt 90 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Frontier Technologies R&D Program of Jiangsu, Lingang Laboratory.
Themen: Schlaganfall
Abstract (Originalsprache)
Poststroke neurorehabilitation is limited by the poor regenerative capacity of adult neurons. Although neural stem cells (NSCs) can generate new neurons, their reparative potential is constrained by inefficient delivery to cerebral lesions and a hostile regenerative niche. Here, analysis of a single‐nucleus transcriptomic dataset revealed pronounced dysfunction and intercellular crosstalk among neurons, microglia, and NSCs, highlighting redox imbalance and impaired nitric oxide (NO) signaling as potential therapeutic targets. Guided by these findings, we develop FCeO 2 @GLp, a pathogenesis‐adaptive nanotherapeutic integrating reactive oxygen species scavenging, NO replenishment and immune modulation within cerebral ischemic microenvironment. Following intranasal administration, FCeO 2 @GLp actively adheres to the olfactory epithelium (OE), reaches infarcted brain regions, releases cerium oxide (CeO 2 ) nanozyme, fingolimod, and a NO donor in response to local acidity. This coordinated strategy alleviates oxidative stress, reprograms microglia, protects neurons, and enhances NSC proliferation and neuronal differentiation. Consequently, FCeO 2 @GLp effectively reduces infarct volume and cerebral edema during the acute phase, and improves long‐term neurological function and survival, establishing a lesion‐responsive strategy for poststroke neural repair.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing, P. R. China.
- NMPA Key Laboratory for Research and Evaluation of Cosmetics, China Pharmaceutical University, Nanjing, P. R. China.
- State Key Laboratory of Natural Medicines, Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, P. R. China.
- Institute of Innovative Drug, China Pharmaceutical University, Nanjing, P. R. China.
- Institute for Experimental Molecular Imaging, Uniklinik RWTH Aachen and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany.
Förderung
- National Natural Science Foundation of China
- Frontier Technologies R&D Program of Jiangsu
- Lingang Laboratory
- Alexander von Humboldt Foundation
- Alexander von Humboldt-Stiftung
Zitieren
APA
Yin, Y., Wang, Z., Xue, M., Zhao, Q., Li, Z., Shu, W., Wang, Z., Liu, H., Lv, B., Qin, H., Zhang, Y., Fu, C., Zhu, Y., Wei, Q., Tang, L., & Wang, W. (2026). Intranasal Pathogenesis‐Adaptive Nanotherapeutics Reinstate Regenerative Competence for Post‐Stroke Neural Repair. Advanced Materials. https://doi.org/10.1002/adma.75679
Vancouver
Yin Y, Wang Z, Xue M, Zhao Q, Li Z, Shu W, et al. Intranasal Pathogenesis‐Adaptive Nanotherapeutics Reinstate Regenerative Competence for Post‐Stroke Neural Repair. Advanced Materials. 2026. doi:10.1002/adma.75679
BibTeX
@article{Yin2026,
author = {Yin, Yue and Wang, Zihan and Xue, Mingyang and Zhao, Qiaoqiao and Li, Zixuan and Shu, Weijie and Wang, Zixuan and Liu, Hening and Lv, Bei and Qin, Hao and Zhang, Yi and Fu, Cong and Zhu, Yuanbo and Wei, Qiang and Tang, Lu and Wang, Wei},
title = {Intranasal Pathogenesis‐Adaptive Nanotherapeutics Reinstate Regenerative Competence for Post‐Stroke Neural Repair},
journal = {Advanced Materials},
year = {2026},
doi = {10.1002/adma.75679}
}
EUVIMED